China Biotech Services Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG2152F1014
HKD
0.56
-0.02 (-3.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lee's Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd.
TOT BIOPHARM International Co. Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Charmacy Pharmaceutical Co., Ltd.
Antengene Corp. Ltd.
Clover Biopharmaceuticals Ltd.
China Biotech Services Holdings Ltd.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Lansen Pharmaceutical Holdings Ltd.
Fusen Pharmaceutical Co., Ltd.

Why is China Biotech Services Holdings Ltd. ?

1
Poor long term growth as Operating profit has grown by an annual rate -165.81% of over the last 5 years
2
Flat results in Dec 25
  • OPERATING CASH FLOW(Y) Lowest at HKD -211.78 MM
  • DEBT-EQUITY RATIO (HY) Highest at 200 %
  • INVENTORY TURNOVER RATIO(HY) Lowest at 3.22 times
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -20.00%, its profits have fallen by -61.9%
4
Below par performance in long term as well as near term
  • Along with generating -20.00% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is China Biotech Services Holdings Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
China Biotech Services Holdings Ltd.
-20.0%
0.56
88.57%
Hang Seng Hong Kong
8.76%
0.45
19.63%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.74%
EBIT Growth (5y)
-165.81%
EBIT to Interest (avg)
-12.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.20
Tax Ratio
1.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
107.26%
ROE (avg)
397.22%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.94
EV to EBIT
-21.80
EV to EBITDA
-22.76
EV to Capital Employed
2.06
EV to Sales
8.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.47%
ROE (Latest)
-22.32%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET PROFIT(HY)

Higher at HKD -35.84 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 3.39 times

OPERATING PROFIT MARGIN(Q)

Highest at -74.29 %

RAW MATERIAL COST(Y)

Fallen by -115.16% (YoY

OPERATING PROFIT(Q)

Highest at HKD -25.73 MM

-7What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at HKD -211.78 MM

DEBT-EQUITY RATIO (HY)

Highest at 200 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.22 times

Here's what is working for China Biotech Services Holdings Ltd.

Operating Profit Margin
Highest at -74.29 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Net Profit
Higher at HKD -35.84 MM
than preceding 12 month period ended Dec 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Debtors Turnover Ratio
Highest at 3.39 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Profit
Highest at HKD -25.73 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Raw Material Cost
Fallen by -115.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
At HKD 9.12 MM has Grown at 24.68%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for China Biotech Services Holdings Ltd.

Debt-Equity Ratio
Highest at 200 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at HKD -211.78 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Inventory Turnover Ratio
Lowest at 3.22 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio